Since gaining control of the House, Senate and governor’s office, Colorado Democrats are pushing an aggressive health care agenda. With measures to create a public insurance option, welcome drug importation, lower drug prices, curtail surprise billing and cap insulin copays, the state is becoming a likely model for health policies at the federal level.
The research exaggerates potential savings, cherry-picks evidence and downplays some of the potential tradeoffs.
It’s “déjà vu all over again.”
Because seniors are at higher risk of cognitive impairment, proponents say screening asymptomatic older adults is an important strategy to identify people who may be developing dementia and to improve their care. But the U.S. Preventive Services Task Force cited insufficient evidence the tests are helpful.
UnitedHealthcare is dropping hundreds of physicians from its New Jersey Medicaid network, separating patients from longtime doctors. Physicians charge the insurer is using its market power to shift business to practices it controls.
The California Democratic members of Congress who flipped seven Republican seats two years ago made health care a major campaign issue, criticizing their opponents for voting to repeal the Affordable Care Act. As the Democrats defend their seats in this year’s elections, they are coming back to health care — but the issues are different.
Two drug implants are nearly identical. The one for children has a list price of $37,300. For adults, the list price is $4,400. One dad fought for his daughter to be able to use the cheaper drug.
This claim ‘wouldn’t pass muster’ in a first-year statistics class.
Until very recently, the separate company that runs the emergency department at Nashville General Hospital in Tennessee was continuing to haul patients who couldn’t pay medical bills into court.
Organized labor is divided over whether to support “Medicare for All.” Meanwhile, many of the Democratic presidential candidates seem unable to use the health issue to their advantage. Rebecca Adams of CQ Roll Call, Jennifer Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists offer their favorite health policy stories of the week they think you should read, too.
